Table 2.
Endothelial Cell Type | ICRAC: Electrophysiological and Pharmacological Features | Agonist Used to Reduce the [Ca2+]ER | Intracellular Ca2+ Buffering | Reference |
---|---|---|---|---|
CPAE cells | IR, Erev > +40 mV, depotentiation of the Na+ currents under DVF conditions, inhibited by 10 µM La3+ | Intracellular InsP3 | 12 mM BAPTA | [35] |
HUVECs, hPAECs | IR, Erev > +40 mV, depotentiation of the Na+ currents under DVF conditions, inhibited by 10 µM Gd3+, activated by 5 µM 2-APB | Intracellular dialysis with BAPTA or extracellular thapsigargin | 20 mM BAPTA or [Ca2+]i buffered at 98 nm/L for thapsigargin-evoked currents | [38] |
Abbreviations: 2-APB: 2-Aminoethoxydiphenyl borate; CPAE cells: calf pulmonary artery endothelial cells; DVF: divalent-free; IR: inward rectification; Erev: reversal potential; hPAECs: human pulmonary artery endothelial cells; HUVECs: human umbilical vein endothelial cells.